$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Method for enhancing transdermal drug delivery of electrical drug applicators 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61N-001/30
출원번호 US-0834686 (1992-02-12)
발명자 / 주소
  • Sibalis Dan (Stony Brook NY)
출원인 / 주소
  • Drug Delivery Systems Inc. (New York NY 02)
인용정보 피인용 횟수 : 81  인용 특허 : 0

초록

An electrical transdermal drug applicator provides enhanced drug flow to the bloodstream of the subject by delivering a primary drug into a subject\s circulatory system for therapeutic purposes, and delivering from the same or other reservoir a non-therapeutic counteracting agent to the skin of the

대표청구항

A method of enhancing delivery of at least one drug to the bloodstream of a patient over an extended period of time comprising: providing a transdermal drug applicator comprising an electrical circuit operable in different operational cycles and having reservoir means containing one or more drugs at

이 특허를 인용한 특허 (81)

  1. Yanaki, Jamal S., Active electrode for transdermal medicament administration.
  2. Yanaki, Jamal S., Active transdermal medicament patch and circuit board for same.
  3. Haque,Wasimul; Diakur,James, Aryl sulfonic pyridoxines as antiplatelet agents.
  4. Flower Ronald J., Awakenable iontophoretic/delivery device for reducing electrical sensation upon application thereof.
  5. Haque, Wasimul, Cardioprotective phosohonates and malonates.
  6. Haque, Wasimul, Cardioprotective phosphonates and malonates.
  7. Haque, Wasimul, Cardioprotective phosphonates and malonates.
  8. Haque, Wasimul, Cardioprotective phosphonates and malonates.
  9. Haque,Wasimul, Cardioprotective phosphonates and malonates.
  10. Haque,Wasimul, Cardioprotective phosphonates and malonates.
  11. Imran, Mir, Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use.
  12. Imran, Mir, Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use.
  13. Haque, Wasimul; Diakur, James; Pham, Vinh; Rehman, Atiq; Whitney, Tara; Omar, Mohammed; Yi, Seng; Khan, A. Qasim, Dual antiplatelet/anticoagulant pyridoxine analogs.
  14. Cockburn, John Francis; Cockburn, Donald James Alexander; Wemyss-Holden, Simon, Electro-surgical needle apparatus.
  15. Surti, Vihar; Sigmon, John, Endoscopic ultrasound ablation needle.
  16. Charles L. Brown, III ; Neville Crawford GB, Iontophoresis electroporation and combination patches for local drug delivery to body tissues.
  17. Crawford, Neville; Brown, III, Charles L., Iontophoresis, electroporation and combination patches for local drug delivery to body tissues.
  18. Imran, Mir, Iontophoretic apparatus and method for marking of the skin.
  19. Imran, Mir, Iontophoretic apparatus and method for marking of the skin.
  20. Imran, Mir, Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes.
  21. Imran, Mir, Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes.
  22. Imran, Mir, Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes.
  23. Imran, Mir, Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes.
  24. Eppstein Jonathan A., Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue.
  25. Imran, Mir, Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent.
  26. Miller,David J.; Higuchi,William I.; Li,Kevin; Flynn,Gordon L., Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent.
  27. Smith, Alan; Eppstein, Jonathan A.; Messier, Bernadette; Novakovic, Zoran; McRae, Stuart, Method for transdermal delivery of permeant substances.
  28. Smith, Alan; Eppstein, Jonathan A.; Messier, Bernadette; Novakovic, Zoran; McRae, Stuart, Method for transdermal delivery of permeant substances.
  29. Imran, Mir; Hashim, Mir; Patel, Sanjay; Berenson, Ronald J., Method for transdermal iontophoretic delivery of chelated agents.
  30. Imran, Mir; Hashim, Mir; Patel, Sanjay; Berenson, Ronald J., Method for transdermal iontophoretic delivery of chelated agents.
  31. Imran, Mir A.; Andersen, Dean P.; Malhotra, Vikram; Mangogna, George Andrew, Methods and architecture for power optimization of iontophoretic transdermal drug delivery.
  32. Li, S. Kevin; Higuchi, William I.; Zhu, Honggang; Song, Yang, Methods for delivering agents using alternating current.
  33. S. Kevin Li ; William I. Higuchi ; Honggang Zhu ; Yang Song, Methods for extracting substances using alternating current.
  34. Eppstein, Jonathan A., Microporation of tissue for delivery of bioactive agents.
  35. Eppstein, Jonathan A., Microporation of tissue for delivery of bioactive agents.
  36. Eppstein, Jonathan A., Microporation of tissue for delivery of bioactive agents.
  37. Imran, Mir, Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes.
  38. Imran, Mir A., Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes.
  39. Berenson, Ronald J., Patches and method for the transdermal delivery of a therapeutically effective amount of iron.
  40. Berenson, Ronald J., Patches and methods for the transdermal delivery of a therapeutically effective amount of iron.
  41. Haque, Wasimul, Pyridoxal analogues and methods of treatment.
  42. Haque,Wasimul; Charlton,James L., Pyridoxal analogues and methods of treatment.
  43. Wasimul Haque CA, Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics.
  44. Haque, Wasimul, Pyridoxine and pyridoxal analogues: new uses.
  45. Haque,Wasimul, Pyridoxine and pyridoxal analogues: new uses.
  46. Haque, Wasimul, Pyridoxine and pyridoxal analogues: novel uses.
  47. Imran, Mir; Hashim, Mir; McLaughlin, Glen; Arastu, Huma; Vaidyanathan, Rekha; Harris, Joel; Korupolu, Radhika; Mangogna, Andrew; Ong, Chang; Patel, Sanjay; Wang, Lu; Williams, Timothy, System and method for biphasic transdermal iontophoretic delivery of therapeutic agents.
  48. Imran, Mir A.; Imran, Talat; Hashim, Mir, System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings.
  49. Imran, Mir; Imran, Talat; Hashim, Mir, System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings.
  50. Imran, Mir; Hashim, Mir; McLaughlin, Glen; Arastu, Huma; Vaidyanathan, Rekha; Harris, Joel; Korupolu, Radhika; Mangogna, Andrew; Ong, Chang; Patel, Sanjay; Wang, Lu; Williams, Timothy, System and method for biphasic transdermal iontophreotic delivery of therapeutic agents.
  51. Imran, Mir A.; Imran, Talat; Hashim, Mir, System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation.
  52. Imran, Mir; Imran, Talat; Hashim, Mir, System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation.
  53. Wasimul Haque CA, Therapeutics for cardiovascular and related diseases.
  54. Eppstein, Jonathan; McRae, Stuart, Transdermal integrated actuator device, methods of making and using same.
  55. Eppstein, Jonathan; McRae, Stuart, Transdermal integrated actuator device, methods of making and using same.
  56. Eppstein, Jonathan; McRae, Stuart, Transdermal integrated actuator device, methods of making and using same.
  57. McRae, Stuart; Bowerman, Wendy E.; Braun, Stephen Wilson; Spiehl, Regina; Messier, Bernadette; Farquhar, David; Henkel, Erin Koch; O'Leary, Jeremiah Peter; Fisher, Mark James; Kascak, Uros; Lantz, Loren J.; Novakovic, Zoran; Eppstein, Jonathan, Transdermal porator and patch system and method for using same.
  58. Messier, Bernadette; Novakovic, Zoran; O'Leary, Jeremiah Peter; Spiehl, Regina; Bowerman, Wendy E.; Braun, Stephen Wilson; Eppstein, Jonathan; Farquhar, David; Fisher, Mark James; Kascak, Uros; Henkel, Erin Koch; Lantz, Loren J.; McRae, Stuart, Transdermal porator and patch system and method for using same.
  59. Messier, Bernadette; Novakovic, Zoran; O'Leary, Jeremiah Peter; Spiehl, Regina; Bowerman, Wendy E.; Braun, Stephen Wilson; Eppstein, Jonathan; Farquhar, David; Fisher, Mark James; Kascak, Uros; Henkel, Erin Koch; Lantz, Loren J.; McRae, Stuart, Transdermal porator and patch system and method for using same.
  60. Anderson, Carter R.; Sembrowich, Walter L.; Morris, Russell L.; Cohen, Robert, Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis.
  61. Anderson, Carter R.; Sembrowich, Walter L.; Morris, Russell L.; Cohen, Robert, Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis.
  62. Anderson, Carter R.; Sembrowich, Walter L.; Morris, Russell L.; Cohen, Robert, Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis.
  63. Sethi,Rajat; Haque,Wasimul, Treating of cardiovascular and related pathologies.
  64. Dhalla Naranjan S.,CAX ; Sethi Rajat,CAX ; Dakshinamurti Krishnamurti,CAX, Treatment of cardiovascular and related pathologies.
  65. Sethi, Rajat; Haque, Wasimul, Treatment of cardiovascular and related pathologies.
  66. Sethi,Rajat; Haque,Wasimul, Treatment of cardiovascular and related pathologies.
  67. Sethi,Rajat; Haque,Wasimul, Treatment of cardiovascular and related pathologies.
  68. Sethi,Rajat; Haque,Wasimul, Treatment of cardiovascular and related pathologies.
  69. Sethi,Rajat; Haque,Wasimul, Treatment of cardiovascular and related pathologies.
  70. Sethi,Rajat; Haque,Wasimul, Treatment of cardiovascular and related pathologies.
  71. Haque, Wasimul; Sethi, Rajat, Treatment of cerebrovascular disease.
  72. Haque, Wasimul; Sethi, Rajat, Treatment of cerebrovascular disease.
  73. Rajat Sethi CA; Wasimul Haque CA, Treatment of diabetes and related pathologies.
  74. Becker, Cyrus K.; Pfister, Jürg R.; Rescourio, Gwenaella; Venkatraman, Meenakshi S.; Zhang, Xiaoming, Treprostinil derivative compounds and methods of using same.
  75. Becker, Cyrus K.; Pfister, Jürg R.; Rescourio, Gwenaella; Venkatraman, Meenakshi S.; Zhang, Xiaoming, Treprostinil derivative compounds and methods of using same.
  76. Becker, Cyrus K.; Pfister, Jürg R.; Rescourio, Gwenaella; Venkatraman, Meenakshi S.; Zhang, Xiaoming, Treprostinil derivative compounds and methods of using same.
  77. Becker, Cyrus K.; Venkatraman, Meenakshi S.; Zhang, Xiaoming, Treprostinil derivative compounds and methods of using same.
  78. Zhang, Xiaoming; Venkatraman, Meenakshi S.; Becker, Cyrus K., Treprostinil derivatives and compositions and uses thereof.
  79. Zhang, Xiaoming; Venkatraman, Meenakshi S.; Becker, Cyrus K., Treprostinil derivatives and compositions and uses thereof.
  80. Zhang, Xiaoming; Venkatraman, Meenakshi S.; Becker, Cyrus K., Treprostinil derivatives and compositions and uses thereof.
  81. Zhang, Xiaoming; Venkatraman, Meenakshi S.; Becker, Cyrus K., Treprostinil derivatives and compositions and uses thereof.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로